Literature DB >> 21086073

Poor efficacy of BEP polychemotherapy in metastatic spermatocytic seminoma.

Thomas Horn1, Stephan Schulz, Tobias Maurer, Jürgen E Gschwend, Hubert R Kübler.   

Abstract

Metastatic spermatocytic seminoma is an extremely rare disease. No chemotherapeutic regimen is established and the use of adjuvant radiation therapy after orchiectomy as frequently performed for classical seminoma is unclear. We report the third case of proven spermatocytic seminoma metastatic in the literature and provide a review of the literature. Administering BEP polychemotherapy as in classical seminoma was poorly effective in reducing the retroperitoneal mass in a patient with spermatocytic seminoma. A review of the literature showed that all the three described patients developing metastatic disease did not receive adjuvant radiation therapy after orchiectomy, which might be considered in high-risk cases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21086073     DOI: 10.1007/s12032-010-9739-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  10 in total

1.  Study on the semome.

Authors:  P MASSON
Journal:  Rev Can Biol       Date:  1946

Review 2.  Metastatic spermatocytic seminoma--an extremely rare disease.

Authors:  Hannes Steiner; Christian Gozzi; Irmgard Verdorfer; Gregor Mikuz; Georg Bartsch; Alfred Hobisch
Journal:  Eur Urol       Date:  2005-11-08       Impact factor: 20.096

3.  Reactivity of germ cell maturation stage-specific markers in spermatocytic seminoma: diagnostic and etiological implications.

Authors:  H Stoop; R van Gurp; R de Krijger; A Geurts van Kessel; B Köberle; W Oosterhuis; L Looijenga
Journal:  Lab Invest       Date:  2001-07       Impact factor: 5.662

4.  VASA is a specific marker for both normal and malignant human germ cells.

Authors:  Anne-Marie Zeeman; Hans Stoop; Marjan Boter; Ad J M Gillis; Diego H Castrillon; J Wolter Oosterhuis; Leendert H J Looijenga
Journal:  Lab Invest       Date:  2002-02       Impact factor: 5.662

5.  Spermatocytic seminoma: clinicopathological study of 22 cases.

Authors:  A Talerman
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

Review 6.  Spermatocytic seminoma.

Authors:  J N Eble
Journal:  Hum Pathol       Date:  1994-10       Impact factor: 3.466

7.  The spermatocytic seminoma: views on pathogenesis.

Authors:  J Müller; N E Skakkebaek; M C Parkinson
Journal:  Int J Androl       Date:  1987-02

8.  Metastatic spermatocytic seminoma. A case report with light microscopic, ultrastructural, and immunohistochemical findings.

Authors:  J Matoska; D Ondrus; M Hornák
Journal:  Cancer       Date:  1988-09-15       Impact factor: 6.860

9.  Placental-like alkaline phosphatase and DNA flow cytometry in spermatocytic seminoma.

Authors:  I Dekker; T Rozeboom; J Delemarre; A Dam; J W Oosterhuis
Journal:  Cancer       Date:  1992-02-15       Impact factor: 6.860

10.  Spermatocytic seminoma: a review.

Authors:  Peter W M Chung; Andrew J S Bayley; Joan Sweet; Michael A S Jewett; Betty Tew-George; Mary K Gospodarowicz; Padraig R Warde
Journal:  Eur Urol       Date:  2004-04       Impact factor: 20.096

  10 in total
  4 in total

1.  Spermatocytic seminoma at the National Institute of Oncology in Morocco.

Authors:  Ghizlane G Raiss; Marwane M Benatiya Andaloussi; Soundouss S Raissouni; Hind H Mrabti; Hassan H Errihani
Journal:  BMC Res Notes       Date:  2011-06-29

2.  Clinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential.

Authors:  Philip Savage
Journal:  BMC Cancer       Date:  2015-01-21       Impact factor: 4.430

3.  An unusual case of spermatocytic seminoma in 80 year-old-patient: A case report.

Authors:  Moez Rahoui; Boulma Rami; Hassen Khouni
Journal:  Ann Med Surg (Lond)       Date:  2021-12-25

4.  A rare case of bilateral sequential spermatocytic seminoma.

Authors:  Ning Xu; Fubiao Li; Runhui Tian; Mingming Shao; Lingyun Liu; Kaimin Guo
Journal:  World J Surg Oncol       Date:  2013-08-06       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.